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Abstract: Background: Thumb carpometacarpal osteoarthritis (CMC OA) is a common disorder that
interferes with the ability to perform the activities of daily life. The purpose of this study was to
investigate the immediate effects of ischemic compression on myofascial trigger points (MTrPs) in
the first dorsal interosseous (FDI) muscle in patients with the diagnosis of thumb CMC OA. Methods:
In a quasi-experimental clinical trial, thirty-one patients, 87% female (age: 82 ± 9.4 years), with
thumb CMC OA, were consecutively assigned to either an experimental treatment that included
the ischemic compression of the FDI MTrP or a sham treatment of the FDI MTrP for one session.
The main outcome considered in the study was the pressure pain threshold (PPT). Measurements
were taken pre- and post-treatment and at a 1-week follow-up period. Results: The PPT over the right
(affected) FDI muscle showed statistically significant differences between groups at 1-week follow
up (F = 3.518; p = 0.04) in favor of the experimental group. Conclusions: The ischemic compression
of FDI-MTrPs is an appropriate part of a multimodal treatment to decrease local pain sensitivity in
patients with CMC OA.
Keywords: myofascial pain; myofascial trigger point; osteoarthritis; pain management; pressure
pain threshold
1. Introduction
Thumb carpometacarpal osteoarthritis (CMC OA) is a common disorder that interferes
with the ability to perform activities of daily living [1]. It is the most often reported painful
joint compared to all other hand joints [2], and it is present in 40% of women and up to
25% of men older than 75 years of age. Its diagnosis is based on symptoms such as the
location of pain, tenderness and instability, as well as radiographic evaluation [3]. Potential
intrinsic, posttraumatic and abnormal biomechanical forces have been reported to increase
the probability of the development of CMC OA [4]. The patient with CMC OA reports pain
and weakness that can be a consequence of CMC ligamentous laxity and is associated with
joint hypermobility.
The first dorsal interosseous muscle (FDI) abducts the index finger. Eyler at al. [5] and
Masquelet et al. [6] reported that the FDI muscle also adducts the first CMC joint. Recently,
it has been shown that the contraction of the dynamic stabilizers (mainly FDI) reduces the
subluxation of the CMC and thus the load on the joint, so we can hypothesize that conservative
treatment focused on the FDI muscle could be key in approaching this pathology [7,8].
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Myofascial trigger points (MTrP) are an extremely prevalent cause of persistent pain
disorders in all parts of the body [9]. MTrPs are highly irritable areas in tight bands of skeletal
muscle that are painful when compressed and can elicit referred pain [10]. Although no
specific studies have examined the effectiveness of ischemic compression on MTrPs in patients
with thumb CMC OA, we hypothesize that this treatment may have a potential effect on both
local and widespread sensitivity. Therefore, the purpose of this study was to investigate the
immediate effects of ischemic compression of MTrPs in the FDI muscle in patients with the
diagnosis of thumb CMC OA on both local and widespread sensitivity.
2. Methods
2.1. Study Design
We conducted a double blind (evaluator and statistician) prospective quasi-experimental
clinical trial. The STROBE published guidelines were used to guide the study design of
the trial [11].
2.2. Ethical Consideration
Prior to the initiation of treatment, the participants provided informed consent, and all
study procedures were conducted according to the Declaration of Helsinki. This research
protocol was approved by the Local Ethical Committee of “IRCCS Fondazione Don Carlo
Gnocchi”, Italy, on 24 February 2016.
2.3. Participants
Participants with a medical diagnosis of right thumb CMC OA (grades 3 to 4 using
the Kellgren and Lawrence grades), a positive clinical grind test for CMC OA, and positive
radiographic findings [12] were recruited at Fondazione Don Carlo Gnocchi at Rovato
(Italy) from July to November 2017. The exclusion criteria were having a past medical
history of injuries or previous lesions to the cervical spine, carpal tunnel syndrome, fi-
bromyalgia syndrome, hand surgery, De Quervain’s tenosynovitis or with degenerative
or non-degenerative neurological conditions in which pain perception was altered. None
of the individuals in this study had received prior conservative or surgical interventions
for CMC OA. A priori power calculation was performed to determine sample size. The
calculation was based on the results of other studies of thumb CMC OA patients, to detect
a difference in reliability of 0.98, at 80% power, and a 5% level of significance. The a priori
power calculation determined that 15 individuals were needed in each group (experimental
and control).
2.4. Assessments and Procedure
A physical therapist [PP] trained specifically in the protocol who was blinded to
group assignment and to the purpose of the study assessed the patients and carried out
the outcome measurements at baseline (Pre), immediately post-intervention (Post) and
at 1-week follow up (FU). Baseline assessments included gender, age, dominant hand,
pressure pain threshold (PPT) [13], the brief version of the Disabilities of the Arm, Shoulder
and Hand (Quick-DASH), the Visual Analogue Scale (VAS) and the key pinch strength [14].
The PPT was assessed as a baseline variable but was also considered the main outcome
for the study. PPT is a quantitative sensory test of tissue sensitivity and has been described
as the least amount of pressure applied that produces pain [13]. PPT was measured via
a pressure algometer (Force dial FDK 20, Wagner) [13] and was evaluated bilaterally on
the hand, first at the CMC joint, followed by the FDI. The patients were asked to tell the
examiner the exact moment when the pressure started to change into a pain sensation, in
order to determine at which moment to stop applying pressure. Two measurements were
attained from each point, and the mean was calculated.
Regarding the rest of the baseline assessments, the Quick-DASH questionnaire was
used to assess the patients’ self-reported upper extremity function [14]. The patients’ key
pinch strength was assessed with a mechanical pinch gauge (Baseline, NY, USA) with the
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patient sitting with their shoulder adducted, forearm in neutral rotation and the elbow
flexed to 90◦ [15].
After completion of the outcome questionnaires and baseline data collection, partici-
pants were consecutively assigned to either the experimental or sham group by a different
physical therapist (MPL) who was blinded to the baseline assessments. The physical thera-
pist (MPL) diagnosed the MTrPs in the FDI muscle and performed the interventions. To
diagnose MTrPs, the patient laid on a mat in a supine position with the forearm held in a
neutral position, while the physical therapist (MPL) palpated the muscles perpendicular to
the fibers’ direction looking for taut bands and progressed longitudinally along the taut
band to determine if there was a painful area or nodule in the taut band, and if the painful
area corresponded with a nodule [16]. When a MTrP was diagnosed, the physical therapist
(MPL) performed a compression test, which consisted of applying a sustained manual
pressure for twenty seconds and then asked the patient if they had any referred pain, to
classify the MTrP as either active or latent [16]. If the compression test reproduced referred
pain that was familiar for the patient, the MTrPs were considered active. During all the
palpations when a hypersensitive nodule was found in the FDI, the therapist asked the
following questions with a yes or no response.
- Is there a taut band?
- Is there a hypersensitive point?
- Is there a nodule coinciding with the hypersensitive point?
- Does compression provoke referred pain familiar to the patient?
After diagnosing MtrPs, the experimental group received a treatment that consisted of
an ischemic compression over the MTrP of the FDI for 1 min, until the subject experienced
pain. The sham/control group received a treatment which consisted of a digital touch
applied (without pressure) to the MTrP of the FDI for 1 min [Figure 1]. After the treatment,
patients were evaluated again by the blinded physical therapist (PP), who measured the
PPT on the bilateral CMC joints and bilateral FDI MTrPs. After the experimental or sham
treatment, participants in both groups received usual care consisting of a passive range of
motion of the hand and exercises once a day for one week.
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2.5. Statistical nalysis
ata ere analyzed with SPSS for Windows (V.22, IBM, Armonk, NY, USA). The re-
sults are expressed as the means and standard deviations (SDs). The Kolmogorov–Smirnov
test was used to determine if there was a normal distribution of the data. A two-way,
mixed-model ANOVA (PPTs (MTrP in FDI muscle, first at the CMC joint, side (dominant,
non-dominant), time point (pre, post-treatment and FU)) was applied to determine the
effect of ischemic compression applied to the MTrP of the FDI muscle or the CMC joint
OA. Where appropriate, univariate contrast and Bonferroni-adjusted post-hoc analyses
were performed. The analysis of variance (ANOVA) was used to determine the difference
over time (pre, post-treatment and FU) and to compare the outcome mean scores of the
within-subjects factor and group (experimental or sham) as the between-subjects factor. The
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statistical analysis was conducted at a 95% confidence level, and p < 0.05 was considered
statistically significant. Mauchly’s sphericity test was carried out to validate a repeated
measures analysis of variance.
3. Results
3.1. Demographic and Clinical Data of Participants
Thirty-one (n = 31) patients with thumb CMC OA (mean ± SD age: 82 ± 9.5 years;
87% female) agreed to participate in the study and met all eligibility criteria. Sixteen
patients were assigned to the experimental group and 15 patients to the sham group. None
of the subjects modified their regular pharmacologic treatment during the study. No
participants dropped out during the study or reported adverse effects after the treatment.
The baseline characteristics were similar between groups (Table 1).
Table 1. Baseline demographics for both groups *.
Exp Group (n = 16) Con Group (n = 15)
Age (n, mean ± SD) 82.6 ± 9.5 81.40 ± 8.3
Gender, female (n, %) 15, 93% 12, 80%
Dominant hand, right (n, %) 16, 100% 15, 100%
Quick-DASH 21.7 ± 11.7 21.8 ± 13.4
Key pinch, right (affected) 3.1 ± 1.4 3.4 ± 1.8
Key pinch, left (non-affected) 3.0 ± 1.3 3.3 ± 1.9
VAS-key pinch, right (affected) 1.1 ± 2.3 1.1 ± 2.6
VAS-key pinch, left (non-affected) 0.9 ± 1.8 0.6 ± 2.0
VAS.24, right (affected) 0.7 ± 1.7 0.7 ± 1.6
VAS.24, left (non affected) 0.7 ± 1.6 0.4 ± 1.3
PPT Findings (n, mean ± SD)
FDI Muscle, right (affected) 1.8 ± 0.7 1.8 ± 0.6
FDI Muscle, left (non affected) 2.0 ± 0.7 1.8 ± 0.6
* Data are expressed as means ± standard deviations (SD); VAS: visual analogue scale; PPT: pressure pain
threshold.
3.2. Pressure Pain Sensitivity
The ICCs for the intraexaminer reliability of PPT measurements ranged from 0.938 to
0.990 for the affected side and from 0.913 to 0.977 for the unaffected side. The SEMs ranged
from 0.07 to 0.19 kg/cm2 for both sides.
For PPTs measured over the first CMC joint, the 2 × 2 × 3 ANOVA revealed no significant
group × time × side (F = 0.559; p = 0.575), group × time (F = 0.694; p = 0.504), side × time
(F = 1.718; p = 0.189) or group × side (F = 1.618; p = 0.215) interactions (Table 2). There was
also no significant effect of time (F = 0.883; p = 0.420) or side (F = 0.023; p = 0.880).




PPT (kg/cm2) Post Minus Pre FU Minus Pre
Exp Con Exp Con Exp Con
(n = 16) (n = 15) (n = 16) (n = 15) (n = 16) (n = 15)
Right Left Right Left Right Left Right Left Right Left Right Left
First CMC joint 2.0 2.0 2.2 2.1 0.05 −0.2 0.2 0.1 0.1 0.02 0.2 0.08
(0.7) (0.4) (0.6) (0.6) (0.2) (0.1) (0.2) (0.1) (0.1) (0.1) (0.1) (0.1)
MTrP-FDI
1.6 1.9 1.8 1.9 0.2 0.0 0.1 0.0 0.3 * 0.0 0.1 0.1
(0.4) (0.3) (0.7) (0.5) (0.1) (0.1) (0.1) (0.1) (0.6) (0.7) (0.1) (0.1)
Exp = experimental group; Con = control group; CMC = carpo-metacarpal joint; PPT = pressure-pain threshold; FU (follow up). * Right
hand (affected); left hand (non-affected).
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For PPTs measured over the FDI-MTrP, the 2 × 2 × 3 ANOVA revealed no statistically
significant interaction for group × time × side (F = 1.632; p = 0.216), side × time (F = 1.618;
p = 0.218) or group × side (F = 0.863; p = 0.361). However, there was a statistically significant
group × time interaction (F = 3.518; p = 0.04) between the mean scores of the patients
that received the experimental protocol exhibiting greater PPT over the right FDI-MTrP
(p < 0.024) as compared to those that received the sham treatment at the 1-week FU.
4. Discussion
The present study showed for the first time that ischemic compression of the FDI-
MTrP led to a local reduction in the pressure pain sensitivity. Different studies have shown
that the compression of MTrPs increases the PPTs. For example, the study conducted by
Ziaeifar et al. showed a PPT increase after upper trapezius MTrP compression [17]. In
line with this, the study conducted by Sohns et al. [18] showed that both manual MTrP
compression therapy and sham manual therapy led to an increase in the shoulder PPTs,
although the increase was higher in the experimental group. These results contrast with
our research where no difference between groups on the affected side was found for the
FDI PPTs immediately after the compression, but rather at the 1-week FU.
However, our results are in line with those of De Meulemeester et al., who did not
find changes in the PPTs immediately after the manual compression of shoulder MTrPs but
found significant changes after 4 weeks of treatment [19]. Little is known about the working
mechanisms underlying the effects of manual compression. It has been hypothesized that
compression effects may depend on reactive hyperemia, counter-irritant effects or a spinal
reflex mechanism resulting in a release of muscle spasm [20]. However, another possible
reason for the differences between studies could be the degree of sensitization, which may
depend on the baseline levels of pressure pain sensitivity. In our study, we were not able to
compare our results with other studies as there are no previous studies measuring the PPTs
in the FDI muscle. Nevertheless, we hypothesize that the low PPTs existing in patients
with CMC OA could explain the lack of effects immediately after manual compression.
There is some research regarding the evidence that central sensitization plays a role in
CMC OA chronic and recurring pain [21]. In our study, the beneficial effects of localized
pressure to reduce hypersensitivity at the FDI region are limited. A positive response
was obtained after 1 week and only for the affected side, which points to the possibility
that manual compression techniques of MTrPs may play a role in the local, but not in the
widespread, sensitivity in patients with thumb CMC OA.
5. Conclusions
The ischemic compression of FDI-MTrPs is an appropriate part of a multimodal
treatment to decrease local pain sensitivity in patients with CMC OA. Further studies
including a control group and longer treatments are needed to better understand the effects
of the ischemic compression of MTrPs in patients with CMC OA.
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